In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy

Cardiovascular Research

Volumn 106, Issue 2, 2015, Pages 249-260

  Seymour, Anne Marie L ^a   Giles, Lucia ^b   Ball, Vicky ^b   Miller, Jack J ^b   Clarke, Kieran ^b   Carr, Carolyn A ^b   Tyler, Damian J ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

13C magnetic resonance spectroscopy; Cardiac hypertrophy; Dynamic nuclear polarization; Metabolic remodelling; Pyruvate dehydrogenase

Indexed keywords

3 HYDROXYBUTYRIC ACID; CARBON 13; CHOLESTEROL; GLUCOSE; INSULIN; LACTIC ACID; PYRUVATE DEHYDROGENASE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HEART EJECTION FRACTION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIPID DIET; MALE; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUGAR INTAKE; WESTERN DIET; ABDOMINAL AORTA; ANIMAL; ANIMAL FOOD; CARDIOMEGALY; DISEASE MODEL; ENERGY METABOLISM; HEART FAILURE; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMAL FEED; ANIMALS; AORTA, ABDOMINAL; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HEART FAILURE; MALE; OXIDATION-REDUCTION; RATS, SPRAGUE-DAWLEY;

EID: 84929103952     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv101     Document Type: Article

References (42)

1. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006;367:356-367.
2. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Bio 2006;7:589-600.
3. Neubauer S. The failing heart-an engine out of fuel. New Engl J Med 2007;356: 1140-1151.
4. Doenst T, Pytel G, Schrepper A, Amorim P, Farber G, Shingu Y, Mohr FW, Schwarzer M. Decreased rates ofsubstrate oxidationexvivo predict the onsetof heart failure and contractile dysfunction in rats with pressure overload. Cardiovasc Res 2010;86:461-470.
5. Fillmore N, Lopaschuk GD. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim Biophys Acta 2013;1833:857-865.
6. Madrazo JA, Kelly DP. The PPAR trio: regulators of myocardial energy metabolism in health and disease. J Mol Cell Cardiol 2008;44:968-975.
7. Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circ Res 2007;101:335-347.
8. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncouplingimpair myocardial energetics in obesity. Circulation 2005;112:2686-2695.
9. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001;107:813-822.
10. Wilson CR, Tran MK, Salazar KL, Young ME, Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J 2007;406:457-467.
11. Akki A, Seymour AM. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy. Cardiovasc Res 2009;81:610-617.
12. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contributionofoxi-dative metabolism and glycolysisto ATP production in hypertrophied hearts. Am J Physiol 1994;267:H742-H750.
13. Chatham JC, Seymour AM. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 2002;55:104-112.
14. Atherton HJ, Dodd MS, Heather LC, Schroeder MA, Griffin JL, Radda GK, Clarke K, Tyler DJ. Roleof pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolar-ized magnetic resonance spectroscopy study. Circulation 2011;123:2552-2561.
15. Dodd MS, Ball DR, Schroeder MA, LePage LM, Atherton HJ, Heather LC, SeymourA-M, Ashrafian H, Watkins H, Clarke K, Tyler DJ. In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart. Cardiovasc Res 2012;95:69-76.
16. Schroeder MA, Cochlin LE, Heather LC, Clarke K, Radda GK, Tyler DJ. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci USA 2008;105:12051-12056.
17. Cassidy PJ, Schneider JE, Grieve SM, Lygate C, Neubauer S, Clarke K. Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. J Magn Reson Imaging 2004;19:229-237.
18. Tyler DJ, Lygate CA, Schneider JE, Cassidy PJ, Neubauer S, Clarke K. CINE-MR imaging of the normal and infarcted rat heart usingan 11.7Tvertical boreMRsystem.J Cardiov Magn Reson 2006;8:327-333.
19. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of.10, 000 times in liquid-state NMR. Proc Natl Acad Sci USA 2003;100:10158-10163.
20. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 2001;31:269-286.
21. Atherton HJ, Schroeder MA, Dodd MS, Heather LC, Carter EE, Cochlin LE, Nagel S, Sibson NR, Radda GK, Clarke K, Tyler DJ. Validationoftheinvivo assessmentofpyruvate dehydrogenase activity using hyperpolarised 13C MRS. NMR Biomed 2011;24:201-208.
22. Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, Tropp J, Park I, Vigneron DB, Kurhanewicz J, Hurd RE, Nelson SJ. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson 2010;202:85-92.
23. Schneider JE, Cassidy PJ, Lygate C, Tyler DJ, Wiesmann F, Grieve SM, Hulbert K, Clarke K, Neubauer S. Fast, high-resolution invivo cine magnetic resonance imaging innormal and failing mouse hearts on a vertical 11.7 T system. J Magn Reson Imaging 2003;18:691-701.
24. Schneider JE, Wiesmann F, Lygate CA, Neubauer S. Howto perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging. J Cardiov Magn Reson 2006;8:693-701.
25. Boehm EA, Jones BE, Radda GK, Veech RL, Clarke K. Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart C 2001;280:H977-H983.
26. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucosefatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1: 785-789.
27. Schroeder MA, Atherton HJ, Dodd MS, Lee P, Cochlin LE, Radda GK, Clarke K, Tyler DJ. The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized 13C magnetic resonance study. Circ Cardiovasc Imaging 2012; 5:201-209.
28. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990;86:1913-1920.
29. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994;90:1410-1422.
30. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgeneinaninvivo murine model ofcardiac hypertrophy. Proc Natl Acad Sci USA 1991;88:8277-8281.
31. Akki A, Smith K, Seymour AM. Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation. Mol Cell Biochem 2008;311:215-224.
32. Stanley WC, Recchia FA, Lopaschuk GD. Myocardialsubstrate metabolisminthe normal and failing heart. Physiol Rev 2005;85:1093-1129.
33. Turer AT, Malloy CR, Newgard CB, Podgoreanu MV. Energetics and metabolism in the failing heart: important but poorly understood. Curr Opin Clin Nutr 2010;13:458-465.
34. Seymour AM, Chatham JC. The effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase activity. J Mol Cell Cardiol 1997;29:2771-2778.
35. Day SE, Kettunen MI, Gallagher FA, Hu DE, Lerche M, Wolber J, Golman K, Ardenkjaer-Larsen JH, Brindle KM. Detecting tumor responseto treatmentusing hyper-polarized 13C magnetic resonance imaging and spectroscopy. Nat Med 2007;13: 1382-1387.
36. Schroeder MA, Atherton HJ, Ball DR, Cole MA, Heather LC, Griffin JL, Clarke K, Radda GK, Tyler DJ. Real-time assessment of Krebs cycle metabolism using hyperpolar-ized 13C magnetic resonance spectroscopy. FASEB J 2009;23:2529-2538.
37. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 1993;264: 135-144.
38. Qin F, Siwik DA, Luptak I, Hou X, Wang L, Higuchi A, Weisbrod RM, Ouchi N, Tu VH, Calamaras TD, Miller EJ, Verbeuren TJ, Walsh K, Cohen RA, Colucci WS. The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart diseasein mice. Circulation 2012;125:1757-1764, S1751-1756.
39. Vasanji Z, Cantor EJ, Juric D, Moyen M, Netticadan T. Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. Am J Physiol Cell Ph 2006;291:C772-C780.
40. Okere IC, Young ME, McElfresh TA, Chess DJ, Sharov VG, Sabbah HN, Hoit BD, Ernsberger P, Chandler MP, Stanley WC. Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 2006;48:1116-1123.
41. Rennison JH, McElfresh TA, Okere IC, Vazquez EJ, Patel HV, Foster AB, Patel KK, Chen Q, Hoit BD, Tserng KY, Hassan MO, Hoppel CL, Chandler MP. High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart C 2007;292:H1498-H1506.
42. Listenberger LL, Han X, Lewis SE, Cases S, Farese RVJr, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003; 100:3077-3082.